The Drug Development Discussion Group (DDD Group) is an informal moderated forum bringing together research professionals and clinicians interested in drug development. At this session, Dr. Henry Krause of InDanio will discuss revitalizing the drug discovery process with an advanced nuclear receptor-based in vivo screening system.

Speaker: Dr. Henry Krause (InDanio)

Each session has a 30-minute presentation and a 45-minute moderated discussion. For more information on this series or to register for a specific event please contact MaRS at events@marsdd.com.

Generously supported by:

ABOUT THE SPEAKER

Dr. Henry Krause

Dr. Henry Krause is a Professor at the Terrance Donelly Centre for Cellular and Biological Research, University of Toronto as well as at the Banting and Best Department of Medical Research. He's a senior investigator for the CIHR and a Canadian representative on the Society of Developmental Biology Board. His research focusses on the family-wide analysis of the functions, structures and modulators of the nuclear receptor class of transcription factors. Using the fruit fly to develop new technologies and approaches, these technologies have been introduced to zebrafish for the analysis of human nuclear receptors. The success of these new directions has led to the spinoff of a new drug discovery program.

http://www.utoronto.ca/krause/